<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>400-PANOBINOSTAT.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PANOBINOSTAT" rxcui="1603350">
<ATC code="L01XX42" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="STRONG INHIBITORS OF CYP3A4" code="J02-J05" /></DRUG2>
<DESCRIPTION>Risk of increase of the undesirable effects, especially cardiac ones, of the panobinostat due to decrease of its metabolism by the inhibitor</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and EKG. Possible adjustment of the dosage of the panobinostat</COMMENT>
</INTERACTION>
</INTERACTIONS>
